Johnson & Johnson Vision announced the appointment of Peter Menziuso as company group chairman.
Menziuso now leads the full Johnson & Johnson Vision portfolio, including brands such as Acuvue contact lenses, Tecnis family of intraocular lenses and TearScience LipiFlow.
“Peter’s breadth of experience and passion for eye health position him well to lead J&J Vision,” said Ashley McEvoy, executive vice president, worldwide chairman, Johnson & Johnson MedTech. “Peter has built a reputation as a purpose-driven, highly successful global leader, with a deep focus on innovation in service of healthcare professionals and patients.”
Throughout his career of more than 30 years at Johnson & Johnson, Menziuso “has accelerated businesses to high growth by articulating a compelling vision and strategy, building high-performing teams, and strengthening accountability,” according to the release. Menziuso has spent half of his career in roles outside of the U.S. and has deep experience across the healthcare industry, pharmaceutical, biotech and medical devices in a variety of therapeutic areas.
Prior to his appointment as company group chairman, Menziuso was worldwide president for the company’s Vision Care division. In this role, he “created and raised standards of eye care around the world and shaped a portfolio of meaningful solutions to deliver healthy sight for life,” according to the release. He also previously served as U.S. president for vision care.
“We largely intuit life through sight — it’s how we learn, engage, connect. Across my career with Johnson & Johnson, what has fueled me has been the transformational effect we have on people’s lives on such a large scale—that focus continues,” said Menziuso. “As the only eye care company with health at its core as part of Johnson & Johnson, and with a heritage of innovation ‘firsts’, we have the unique opportunity to not just imagine what the future of eye health looks like, but to redefine it.“
Advertisement
Mr. Menziuso has also served as president, North America, cardiovascular and metabolism, Janssen. His earlier roles within Johnson & Johnson included vice president, worldwide marketing; vice president, U.S. sales and market development; and general manager, Canada, for LifeScan.
